Details for Patent: 11,395,828
✉ Email this page to a colleague
Which drugs does patent 11,395,828 protect, and when does it expire?
Patent 11,395,828 protects CAROSPIR and is included in one NDA.
This patent has four patent family members in four countries.
Summary for Patent: 11,395,828
Title: | Spironolactone aqueous compositions |
Abstract: | Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use. |
Inventor(s): | Pipho; Anthony (Winterville, NC), DeHart; Michael Paul (Winterville, NC) |
Assignee: | CMP DEVELOPMENT LLC (Farmville, NC) |
Application Number: | 17/383,761 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 11,395,828
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | CAROSPIR IS INDICATED FOR TREATMENT OF NYHA CLASS III-IV HEART FAILURE AND REDUCED EJECTION FRACTION TO INCREASE SURVIVAL, MANAGE EDEMA, AND TO REDUCE THE NEED FOR HOSPITALIZATION FOR HEART FAILURE | ⤷ Try a Trial | |||
Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | CAROSPIR IS INDICATED AS AN ADD-ON THERAPY FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER AGENTS | ⤷ Try a Trial | |||
Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | CAROSPIR IS INDICATED FOR THE MANAGEMENT OF EDEMA IN ADULT CIRRHOTIC PATIENTS WHEN EDEMA IS NOT RESPONSIVE TO FLUID AND SODIUM RESTRICTION | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,395,828
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 3003028 | ⤷ Try a Trial | |||
European Patent Office | 3368045 | ⤷ Try a Trial | |||
Morocco | 43132 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2017075463 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |